JPRN-UMIN000010240
Completed
未知
Rocuronium-induced neuromuscular block and reversibility with sugammadex at the corrugator supercilii and adductor pollicis muscles - Rocuronium and sugammadex at the corrugator supercilli
ihon University of Medicine Department of Anesthesiology0 sites40 target enrollmentMarch 14, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Surgical patients requiring general anesthesia
- Sponsor
- ihon University of Medicine Department of Anesthesiology
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients having allergic factors to neuromuscular blocking agents 2\) ASA risk 4 and above 3\) BMI 30 and above or below 18\.5 4\)Patients having hepatic and renal disorders
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Reversal of rocuronium induced neuromuscular block by sugammadex for electroconvulsive therapy; crossover designed dose response studyPsychiatric diseaseJPRN-UMIN000007254Tokyo Women's Medical University Hospital20
Completed
Not Applicable
euromuscular blockade induced by rocuronium in the elderly A study of the utility of masseter muscle nerve stimulation and monitoring of masseter muscle contraction responsePatients scheduled for elective surgery requiring general anesthesiaJPRN-UMIN000042488Department of Anesthesiology Nihon University School of Medicine50
Recruiting
Not Applicable
Duration of rocuronium-induced neuromuscular block under total intravenous aneshtesia in pediatric patientJPRN-UMIN000012992Saitama Children's medical center Department of aneshtesiology80
Completed
Phase 3
Sugammadex and Heart FailurePostoperative Neuromuscular BlockNCT01509651Onze Lieve Vrouw Hospital12
Unknown
Not Applicable
The Neuromuscular Effect of Rocuronium in PatientAnesthesiaNCT02657187Go Eun Bae80